Stay updated on LN-144 in Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the LN-144 in Metastatic Uveal Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMinor UI and layout adjustments were made, with no changes to core study information (eligibility criteria, endpoints, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedThe label 'Last Update Posted' on the Study Details page is updated to 'Last Update Posted (Estimated)'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedNew operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.SummaryDifference3%

- Check48 days agoChange DetectedMajor update: new primary contact (Lauren Banks, MD, PhD) with updated phone, email, and address; product revision updated to v3.1.0 and origin noted; former contact and earlier revision are removed.SummaryDifference1%

- Check56 days agoChange DetectedDifference0.0%

- Check63 days agoChange DetectedBroadens eligibility by removing the 3-year prior malignancy exclusion and adds an explicit ban on active concurrent malignancies requiring systemic treatment, with an exception for adjuvant NED cancers on hormone therapy (Revision: v3.0.2, dated 2025-09-11/12).SummaryDifference6%

Stay in the know with updates to LN-144 in Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.